Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 3—March 2008

Research

Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City

Ethan E. Bodle*, Jennifer A. Cunningham*, Phyllis Della-Latta*, Neil W. Schluger*, and Lisa Saiman*Comments to Author 
Author affiliations: *Columbia University, New York, New York, USA;

Main Article

Table 2

Site of disease and species of nontuberculous mycobacteria, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003*

Site of disease No. patients with MAC infection No. patients with RGM infection No. patients with other species infections Total no. patients (%)
Respiratory tract 65 7 9 81 (68.1)
Skin and soft tissue, nonsurgical 2 4 6 12 (10.1)
Surgical sites 0 7 2 9 (7.6)
Bloodstream 2 4 1 7 (5.9)
Lymph node 5 1 0 6 (5.0)
Disseminated 2 0 0 2 (1.7)
Central nervous system 0 1 0 1 (0.8)
Gastrointestinal tract 0 0 1 1 (0.8)
All body sites 76 24 19 119 (100)

*MAC, Mycobacterium avium complex; RGM, rapidly growing mycobacteria.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO